ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES

Conformationally Restricted Competitive Antagonists of Human/Rat Corticotropin-Releasing Factor

Cite this: J. Med. Chem. 1994, 37, 10, 1450–1459
Publication Date (Print):May 1, 1994
https://doi.org/10.1021/jm00036a010
    ACS Legacy Archive

    Article Views

    109

    Altmetric

    -

    Citations

    LEARN ABOUT THESE METRICS
    Other access options

    Note: In lieu of an abstract, this is the article's first page.

    Free first page

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Cited By

    This article is cited by 57 publications.

    1. Maoqing Dong, Jerez A. Te, Xiequn Xu, Jinhui Wang, Delia I. Pinon, Laura Storjohann, Andrew J. Bordner, and Laurence J. Miller . Lactam Constraints Provide Insights into the Receptor-Bound Conformation of Secretin and Stabilize a Receptor Antagonist. Biochemistry 2011, 50 (38) , 8181-8192. https://doi.org/10.1021/bi2008036
    2. Jean Rivier,, Jozsef Gulyas,, Koichi Kunitake,, Michael DiGruccio,, Jeffrey P. Cantle,, Marilyn H. Perrin,, Cindy Donaldson,, Joan Vaughan,, Mulugeta Million,, Guillaume Gourcerol,, David W. Adelson,, Catherine Rivier,, Yvette Taché, and, Wylie Vale. Stressin1-A, a Potent Corticotropin Releasing Factor Receptor 1 (CRF1)-Selective Peptide Agonist. Journal of Medicinal Chemistry 2007, 50 (7) , 1668-1674. https://doi.org/10.1021/jm0613875
    3. Sam R. J. Hoare,, Sue K. Sullivan,, David A. Schwarz,, Nicholas Ling,, Wylie W. Vale,, Paul D. Crowe, and, Dimitri E. Grigoriadis. Ligand Affinity for Amino-Terminal and Juxtamembrane Domains of the Corticotropin Releasing Factor Type I Receptor:  Regulation by G-Protein and Nonpeptide Antagonists. Biochemistry 2004, 43 (13) , 3996-4011. https://doi.org/10.1021/bi036110a
    4. J. Rivier,, J. Gulyas,, D. Kirby,, W. Low,, M. H. Perrin,, K. Kunitake,, M. DiGruccio,, J. Vaughan,, J. C. Reubi,, B. Waser,, S. C. Koerber,, V. Martinez,, L. Wang,, Y. Taché, and, W. Vale. Potent and Long-Acting Corticotropin Releasing Factor (CRF) Receptor 2 Selective Peptide Competitive Antagonists. Journal of Medicinal Chemistry 2002, 45 (21) , 4737-4747. https://doi.org/10.1021/jm0202122
    5. Jean E. Rivier,, John Porter,, Laura A. Cervini,, Sabine L. Lahrichi,, Dean A. Kirby,, R. Scott Struthers,, Steven C. Koerber, and, Catherine L. Rivier. Design of Monocyclic (1−3) and Dicyclic (1−3/4−10) Gonadotropin Releasing Hormone (GnRH) Antagonists. Journal of Medicinal Chemistry 2000, 43 (5) , 797-806. https://doi.org/10.1021/jm9901172
    6. Jean E. Rivier,, Dean A. Kirby,, Sabine L. Lahrichi,, Anne Corrigan,, Wylie W. Vale, and, Catherine L. Rivier. Constrained Corticotropin Releasing Factor Antagonists (Astressin Analogues) with Long Duration of Action in the Rat. Journal of Medicinal Chemistry 1999, 42 (16) , 3175-3182. https://doi.org/10.1021/jm9902133
    7. Laura Cervini,, Paula Theobald,, Anne Corrigan,, A. Grey Craig,, Catherine Rivier,, Wylie Vale, and, Jean Rivier. Corticotropin Releasing Factor (CRF) Agonists with Reduced Amide Bonds and Ser7 Substitutions. Journal of Medicinal Chemistry 1999, 42 (4) , 761-768. https://doi.org/10.1021/jm980607e
    8. Steven C. Koerber,, Jozsef Gulyas,, Sabine L. Lahrichi,, Anne Corrigan,, A. Grey Craig,, Catherine Rivier,, Wylie Vale, and, Jean Rivier. Constrained Corticotropin-Releasing Factor (CRF) Agonists and Antagonists with i−(i+3) Glu-Xaa-dXbb-Lys Bridges. Journal of Medicinal Chemistry 1998, 41 (25) , 5002-5011. https://doi.org/10.1021/jm980350k
    9. Jean Rivier,, Jozsef Gulyas,, Anne Corrigan,, Vicente Martinez,, A. Grey Craig,, Yvette Taché,, Wylie Vale, and, Catherine Rivier. Astressin Analogues (Corticotropin-Releasing Factor Antagonists) with Extended Duration of Action in the Rat. Journal of Medicinal Chemistry 1998, 41 (25) , 5012-5019. https://doi.org/10.1021/jm980426c
    10. Jean Rivier,, Sabine L. Lahrichi,, Jozsef Gulyas,, Judit Erchegyi,, Steven C. Koerber,, A. Grey Craig,, Anne Corrigan,, Catherine Rivier, and, Wylie Vale. Minimal-Size, Constrained Corticotropin-Releasing Factor Agonists with i−(i+3) Glu−Lys and Lys−Glu Bridges. Journal of Medicinal Chemistry 1998, 41 (14) , 2614-2620. https://doi.org/10.1021/jm980164e
    11. Laura A. Cervini,, Cynthia J. Donaldson,, Steven C. Koerber,, Wylie W. Vale, and, Jean E. Rivier. Human Growth Hormone-Releasing Hormone hGHRH(1−29)-NH2:  Systematic Structure−Activity Relationship Studies. Journal of Medicinal Chemistry 1998, 41 (5) , 717-727. https://doi.org/10.1021/jm970618s
    12. Antonio Miranda,, Sabine L. Lahrichi,, Jozsef Gulyas,, Steven C. Koerber,, Anthony G. Craig,, Anne Corrigan,, Catherine Rivier,, Wylie Vale, and, Jean Rivier. Constrained Corticotropin-Releasing Factor Antagonists with i-(i + 3) Glu−Lys Bridges. Journal of Medicinal Chemistry 1997, 40 (22) , 3651-3658. https://doi.org/10.1021/jm970311t
    13. Alessandro Bisello,, Chizu Nakamoto,, Michael Rosenblatt, and, Michael Chorev. Mono- and Bicyclic Analogs of Parathyroid Hormone-Related Protein. 1. Synthesis and Biological Studies. Biochemistry 1997, 36 (11) , 3293-3299. https://doi.org/10.1021/bi9619029
    14. Feng-Di T. Lung,, Nathan Collins,, Dagmar Stropova,, Peg Davis,, Henry I. Yamamura,, Frank Porreca, and, Victor J. Hruby. Design, Synthesis, and Biological Activities of Cyclic Lactam Peptide Analogues of Dynorphin A(1−11)-NH2. Journal of Medicinal Chemistry 1996, 39 (5) , 1136-1141. https://doi.org/10.1021/jm950369c
    15. Michael Beyermann,, Klaus Fechner,, Jens Furkert,, Eberhard Krause, and, Michael Bienert. A Single-Point Slight Alteration Set as a Tool for Structure−Activity Relationship Studies of Ovine Corticotropin Releasing Factor. Journal of Medicinal Chemistry 1996, 39 (17) , 3324-3330. https://doi.org/10.1021/jm960116z
    16. Huy N. Hoang, Timothy A. Hill, Gloria Ruiz-Gómez, Frederik Diness, Jody M. Mason, Chongyang Wu, Giovanni Abbenante, Nicholas E. Shepherd, David P. Fairlie. Twists or turns: stabilising alpha vs. beta turns in tetrapeptides. Chemical Science 2019, 10 (45) , 10595-10600. https://doi.org/10.1039/C9SC04153B
    17. Ndeye Kebe, Krishnananda Samanta, Priyanka Singh, Joséphine Lai-Kee-Him, Viviana Apicella, Nadine Payrot, Noémie Lauraire, Baptiste Legrand, Vincent Lisowski, Diane-Ethna Mbang-Benet, Michel Pages, Patrick Bastien, Andrey Kajava, Patrick Bron, Jean-François Hernandez, Olivier Coux. The HslV Protease from Leishmania major and Its Activation by C-terminal HslU Peptides. International Journal of Molecular Sciences 2019, 20 (5) , 1021. https://doi.org/10.3390/ijms20051021
    18. Laura Cristina Lima Diniz, Antonio Miranda, Pedro Ismael da Silva Jr.. Human Antimicrobial Peptide Isolated From Triatoma infestans Haemolymph, Trypanosoma cruzi-Transmitting Vector. Frontiers in Cellular and Infection Microbiology 2018, 8 https://doi.org/10.3389/fcimb.2018.00354
    19. Jürgen Sandow. Hypothalamic Hormones. 2016, 3627-3690. https://doi.org/10.1007/978-3-319-05392-9_83
    20. Tatiana M. Domingues, Katia R. Perez, Antonio Miranda, Karin A. Riske. Comparative study of the mechanism of action of the antimicrobial peptide gomesin and its linear analogue: The role of the β-hairpin structure. Biochimica et Biophysica Acta (BBA) - Biomembranes 2015, 1848 (10) , 2414-2421. https://doi.org/10.1016/j.bbamem.2015.07.012
    21. Jürgen Sandow. Hypothalamic Hormones. 2015, 1-76. https://doi.org/10.1007/978-3-642-27728-3_83-1
    22. Jean E. Rivier, Catherine L. Rivier. Corticotropin-releasing factor peptide antagonists: Design, characterization and potential clinical relevance. Frontiers in Neuroendocrinology 2014, 35 (2) , 161-170. https://doi.org/10.1016/j.yfrne.2013.10.006
    23. Diogo V. Lovato, Rogerio Amino, Yamile González, Antonio Miranda, Sergio Schenkman, Aparecida S. Tanaka. Infestin 1R, an intestinal subtilisin inhibitor from Triatoma infestans able to impair mammalian cell invasion by Trypanosoma cruzi. Experimental Parasitology 2011, 129 (4) , 362-367. https://doi.org/10.1016/j.exppara.2011.09.002
    24. Joana Tomomi Sumikawa, Marlon Vilela de Brito, Maria Ligia Rodrigues Macedo, Adriana F. Uchoa, Antonio Miranda, Ana Paula U. Araujo, Rosemeire A. Silva-Lucca, Misako Uemura Sampaio, Maria Luiza Vilela Oliva. The defensive functions of plant inhibitors are not restricted to insect enzyme inhibition. Phytochemistry 2010, 71 (2-3) , 214-220. https://doi.org/10.1016/j.phytochem.2009.10.009
    25. Augen A. Pioszak, Naomi R. Parker, Kelly Suino-Powell, H. Eric Xu. Molecular Recognition of Corticotropin-releasing Factor by Its G-protein-coupled Receptor CRFR1. Journal of Biological Chemistry 2008, 283 (47) , 32900-32912. https://doi.org/10.1074/jbc.M805749200
    26. Sam R. J. Hoare, Beth A. Fleck, Raymond S. Gross, Paul D. Crowe, John P. Williams, Dimitri E. Grigoriadis. Allosteric Ligands for the Corticotropin Releasing Factor Type 1 Receptor Modulate Conformational States Involved in Receptor Activation. Molecular Pharmacology 2008, 73 (5) , 1371-1380. https://doi.org/10.1124/mol.107.042978
    27. Dimitri E. Grigoriadis, Samuel R. J. Hoare. Emerging Anxiolytics: Corticotropin‐Releasing Factor Receptor Antagonists. 2007https://doi.org/10.1002/9780470101001.hcn027
    28. Marcos A. Fázio, Laurence Jouvensal, Françoise Vovelle, Philippe Bulet, M. Terêsa M. Miranda, Sirlei Daffre, Antonio Miranda. Biological and structural characterization of new linear gomesin analogues with improved therapeutic indices. Peptide Science 2007, 88 (3) , 386-400. https://doi.org/10.1002/bip.20660
    29. Hans Gerhard Vogel. Endocrinology. 2007, 1719-1916. https://doi.org/10.1007/978-3-540-70995-4_15
    30. Luis G.M. Moraes, Marcos A. Fázio, Renata F.F. Vieira, Clovis R. Nakaie, M. Terêsa M. Miranda, Shirley Schreier, Sirlei Daffre, Antonio Miranda. Conformational and functional studies of gomesin analogues by CD, EPR and fluorescence spectroscopies. Biochimica et Biophysica Acta (BBA) - Biomembranes 2007, 1768 (1) , 52-58. https://doi.org/10.1016/j.bbamem.2006.08.016
    31. Claudio M. Costa-Neto, Lucas T. Parreiras-e-Silva, Roberto Ruller, Eduardo B. Oliveira, Antonio Miranda, Laerte Oliveira, Richard J. Ward. Molecular modeling of the human eukaryotic translation initiation factor 5A (eIF5A) based on spectroscopic and computational analyses. Biochemical and Biophysical Research Communications 2006, 347 (3) , 634-640. https://doi.org/10.1016/j.bbrc.2006.06.119
    32. Marcos A. Fázio, Vani X. Oliveira, Philippe Bulet, M. Terêsa M. Miranda, Sirlei Daffre, Antonio Miranda. Structure–activity relationship studies of gomesin: Importance of the disulfide bridges for conformation, bioactivities, and serum stability. Peptide Science 2006, 84 (2) , 205-218. https://doi.org/10.1002/bip.20396
    33. Dimitri E Grigoriadis. The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders. Expert Opinion on Therapeutic Targets 2005, 9 (4) , 651-684. https://doi.org/10.1517/14728222.9.4.651
    34. Vani X. Oliveira, Marcos A. Fázio, M. Terêsa M. Miranda, Joelcimar M. da Silva, Jackson C. Bittencourt, Carol F. Elias, Antonio Miranda. Leptin fragments induce Fos immunoreactivity in rat hypothalamus. Regulatory Peptides 2005, 127 (1-3) , 123-132. https://doi.org/10.1016/j.regpep.2004.11.001
    35. Sam R.J. Hoare, Susan K. Sullivan, Jun Fan, Khamkeo Khongsaly, Dimitri E. Grigoriadis. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity. Peptides 2005, 26 (3) , 457-470. https://doi.org/10.1016/j.peptides.2004.10.019
    36. Olaf Jahn, Hossein Tezval, Lars van Werven, Klaus Eckart, Joachim Spiess. Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity. Neuropharmacology 2004, 47 (2) , 233-242. https://doi.org/10.1016/j.neuropharm.2004.03.018
    37. Dirk T. S. Rijkers, John A. W. Kruijtzer, Marja van Oostenbrugge, Eric Ronken, Jack A. J. den Hartog, Rob M. J. Liskamp. Structure–Activity Studies on the Corticotropin Releasing Factor Antagonist Astressin, leading to a Minimal Sequence necessary for Antagonistic Activity. ChemBioChem 2004, 5 (3) , 340-348. https://doi.org/10.1002/cbic.200300769
    38. Sam R.J Hoare, Susan K Sullivan, Anil Pahuja, Nicholas Ling, Paul D Crowe, Dimitri E Grigoriadis. Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligands. Peptides 2003, 24 (12) , 1881-1897. https://doi.org/10.1016/j.peptides.2003.09.002
    39. Eric P Zorrilla, Yvette Taché, George F Koob. Nibbling at CRF receptor control of feeding and gastrocolonic motility. Trends in Pharmacological Sciences 2003, 24 (8) , 421-427. https://doi.org/10.1016/S0165-6147(03)00177-9
    40. Sam R. J. Hoare, Sue K. Sullivan, Nicholas Ling, Paul D. Crowe, Dimitri E. Grigoriadis. Mechanism of Corticotropin-Releasing Factor Type I Receptor Regulation by Nonpeptide Antagonists. Molecular Pharmacology 2003, 63 (3) , 751-765. https://doi.org/10.1124/mol.63.3.751
    41. Dirk T. S. Rijkers, Jack A. J. den Hartog, Rob M. J. Liskamp. An optimized solid phase synthesis strategy— including on‐resin lactamization—of astressin, its retro‐, inverso‐, and retro–inverso isomers as corticotropin releasing factor antagonists. Biopolymers 2002, 63 (2) , 141-149. https://doi.org/10.1002/bip.10052
    42. K. Eckart, O. Jahn, J. Radulovic, M. Radulovic, T. Blank, O. Stiedl, O. Brauns, H. Tezval, T. Zeyda, J. Spiess. Pharmacology and Biology of Corticotropin-Releasing Factor (CRF) Receptors. Receptors and Channels 2002, 8 (3-4) , 163-177. https://doi.org/10.3109/10606820213678
    43. T. M. Reyes, K. Lewis, M. H. Perrin, K. S. Kunitake, J. Vaughan, C. A. Arias, J. B. Hogenesch, J. Gulyas, J. Rivier, W. W. Vale, P. E. Sawchenko. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proceedings of the National Academy of Sciences 2001, 98 (5) , 2843-2848. https://doi.org/10.1073/pnas.051626398
    44. Vani X. Oliveira, M. Terêsa M. Miranda, Jackson C. Bittencourt, Carol F. Elias, Antonio Miranda. Effects of Human Leptin Fragments in Hypothalamic Nucleus C-Fos Expression. 2001, 344-345. https://doi.org/10.1007/978-94-010-0464-0_158
    45. Vani X. Oliveira, Shirley Schreier, Fabio Casallanovo, Therezinha B. Paiva, Antonio C. M. Paiva, Antonio Miranda. Conformational Studies of Angiotensin II Cyclic Analogues. 2001, 723-724. https://doi.org/10.1007/978-94-010-0464-0_337
    46. Paul A Keller, Lynette Elfick, James Garner, Jody Morgan, Adam McCluskey. Corticotropin releasing hormone: therapeutic implications and medicinal chemistry developments. Bioorganic & Medicinal Chemistry 2000, 8 (6) , 1213-1223. https://doi.org/10.1016/S0968-0896(00)00074-2
    47. Andreas Rühmann, Ines Bonk, Andreas K.E Köpke. High-affinity binding of urocortin and astressin but not CRF to G protein-uncoupled CRFR1. Peptides 1999, 20 (11) , 1311-1319. https://doi.org/10.1016/S0196-9781(99)00136-9
    48. Andréa C. Fogaça, Pedro I. da Silva, M. Terêsa M. Miranda, Antonio G. Bianchi, Antonio Miranda, Paulo E.M. Ribolla, Sirlei Daffre. Antimicrobial Activity of a Bovine Hemoglobin Fragment in the Tick Boophilus microplus. Journal of Biological Chemistry 1999, 274 (36) , 25330-25334. https://doi.org/10.1074/jbc.274.36.25330
    49. Andrew V. Turnbull, Joan Vaughan, Jean E. Rivier, Wylie W. Vale, Catherine Rivier. Urocortin Is Not a Significant Regulator of Intermittent Electrofootshock-Induced Adrenocorticotropin Secretion in the Intact Male Rat**This work was supported by NIH Grant DK-26741 and The Foundation for Research.. Endocrinology 1999, 140 (1) , 71-78. https://doi.org/10.1210/endo.140.1.6419
    50. Andreas Rühmann, Ines Bonk, Chijen R. Lin, Michael G. Rosenfeld, Joachim Spiess. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): Development of CRFR2β-selective antisauvagine-30. Proceedings of the National Academy of Sciences 1998, 95 (26) , 15264-15269. https://doi.org/10.1073/pnas.95.26.15264
    51. F. A. Wong, N. J. Anderson, S. J. Juzwin. Determination of a Synthetic Decapeptide in the Plasma of Monkeys and Rats by Narrowbore Highperformance Liquid Chromatography. Journal of Liquid Chromatography & Related Technologies 1998, 21 (7) , 1051-1062. https://doi.org/10.1080/10826079808005868
    52. MARIA PELLEGRINI, MIRIAM ROYO, MICHAEL CHOREV, DALE F. MIERKE. Conformational consequences of i, i + 3 cystine linkages: nucleation for α‐helicity?. The Journal of Peptide Research 1997, 49 (5) , 404-414. https://doi.org/10.1111/j.1399-3011.1997.tb00892.x
    53. Charleen Miller, Jean Rivier. Peptide chemistry: Development of high performance liquid chromatography and capillary zone electrophoresis. Biopolymers 1996, 40 (3) , 265-317. https://doi.org/10.1002/(SICI)1097-0282(1996)40:3<265::AID-BIP2>3.0.CO;2-U
    54. Ping Huang, Gilda H. Loew. Interaction of an Amphiphilic Peptide with a Phospholipid Bilayer Surface by Molecular Dynamics Simulation Study. Journal of Biomolecular Structure and Dynamics 1995, 12 (5) , 937-956. https://doi.org/10.1080/07391102.1995.10508789
    55. Jean Rivier, Catherine Rivier, Steve Sutton, Antonio Miranda, Steven C. Koerber, Jozsef Gulyas, Sabine L. Lahrichi, Anne Corrigan, A. Grey Craig, Wylie Vale. Structure activity relationships (SAR) of corticotropin releasing factor. 1995, 195-198. https://doi.org/10.1007/978-94-010-9069-8_52
    56. J. Rivier, C. Rivier, S. Sutton, A. Miranda, S. C. Koerber, J. Gulyas, S. L. Lahrichi, A. Corrigan, A. G. Craig, W. Vale. SAR of corticotropin releasing factor in relation to its pituitary receptor and binding protein. 1995, 103-104. https://doi.org/10.1007/978-94-011-1468-4_37
    57. A. Miranda, S. Lahrichi, J. Gulyas, C. Rivier, S. Koerber, C. Miller, A. Corrigan, S. Sutton, A. Craig, W. Vale, J. Rivier. Competitive antagonists of the corticotropin releasing factor (CRF) scanned with a i-(i+3) Glu Lys Bridge. , 737-738. https://doi.org/10.1007/0-306-46862-X_321

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    MENDELEY PAIRING EXPIRED
    Your Mendeley pairing has expired. Please reconnect